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Abstract: Cellulose nanocrystals exhibit an interesting combination of mechanical properties
and physical characteristics, which make them potentially useful for a wide range of consumer
applications. However, as the usage of these bio-based nanoﬁbers increases, a greater understanding
of human exposure addressing their potential health issues should be gained. The aim of this
perspective is to highlight how knowledge obtained from studying the biological impact of other
nanomaterials can provide a basis for future research strategies to deduce the possible human health
risks posed by cellulose nanocrystals.
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1. Introduction
Cellulose is the most abundant organic polymer on earth, and can be found in plants, algae,
bacteria, amoeba, and even some marine animals. The polymer is composed of β-(1Ñ4) D-glucose
monomers [1], and in its natural state, cellulose is a hierarchically structured material with different layers
of organization. At the lowest level, the polymer chains are organized in highly ordered and uniaxially
oriented crystalline domains, which are disrupted by disordered amorphous regions. This structure is
the basis for the isolation of different types of nanocellulose from natural cellulosic materials.
Several distinct forms of nanocellulose types, where at least one of the dimensions is on
the nano-scale, exist. The most commonly studied and used forms are bacterial cellulose (BC),
microcrystalline cellulose (MC), microﬁbrillated cellulose (MFC) and cellulose nanocrystals (CNCs) [2,3].
CNCs, which are also referred to as cellulose nanowhiskers (CNWs) or nanocrystalline cellulose
(NCC), are produced by hydrolysis of cellulose pulp with a mineral acid, such as hydrochloric acid [4],
sulphuric acid [5] or phosphoric acid [6]. During the acid treatment, the amorphous portions of the
hierarchically structured material, which are more prone to hydrolysis than the crystalline domains,
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are disintegrated so that only the crystalline parts remain in the form of ‘needle-shaped’ nanoﬁbers.
Cellulose nanocrystals thus made exhibit a length between hundred nm and several μm and a width
between 10 and 50 nm [7,8], dependent on the cellulose source used [9].
CNCs are receiving considerable interest within the research community due to their interesting
and desirable set of properties, which include the renewable nature of their sources, and a combination
of high stiffness and strength and low density [2]. Thus, CNCs have been widely used as reinforcing
ﬁller for a variety of polymers to yield nanocomposites with improved mechanical properties [2,3,10].
In addition, the surface chemistry, made up almost exclusively of hydroxyl groups, renders
nanocellulose as an interesting substrate whose surface can be readily and freely functionalized.
This propensity, together with their biologically benign nature, is driving the use of nanocellulose
within different (bio)materials [10–12]. CNCs have further been used in a broad range of other new
materials applications, including optically [13] and electrically [14,15] active materials, aerogels [16–18],
and mechanically adaptive materials [7,19–25], just to name a few examples.
Fueled by promising outcomes of research projects, and great potential of pilot studies,
an industrial-scale production of CNCs is being undertaken [26], and commercial exploitation of
this nanomaterial has begun. Whilst such an outlook can be seen as advantageous from an application
point of view, i.e., new materials that are cost-effective and that provide advanced, as well as enhanced
qualities over their alternative counterparts, there remain open questions [27] concerning the human
exposure to CNC-based nanomaterials, and furthermore, what the (potentially adverse) human health
effects are following such an exposure.
Over the past three decades, during which the ﬁeld of nanotechnology witnessed constant
expansion, there has been heightened emphasis placed upon the need to develop a thorough
understanding of the biological impact of nano-sized materials. Although the above highlighted
examples illustrate the potential effectiveness of nanocellulose as an application, there remains
a necessity to holistically deduce their possible adverse biological impact due to their nanoscale
properties [28], taking into consideration the pitfalls associated with studying possible nanomaterial
hazard [29]. Thus, with nanocellulose, it is essential to build upon the already formed knowledgebase
of nanomaterial hazard, even via read-across techniques, wherein structurally similar analogues are
used to hypothesize toxicity without experimental testing [30], in order to progress both understanding
and perception of the biological impact of such ‘new’ nanomaterials effectively.
The objective of this perspective is, therefore, to consider how the advancements of nanocellulose
applications have been studied through both in vitro and in vivo investigation, and how this
knowledge within may be attributed towards clarity of current understanding, and future activities
regarding the use of, and biological impact of CNCs.
2. Life-Cycle and Human Exposure of CNCs
As with any other (biodegradable) material, CNCs have a life-cycle [31,32] which, as shown in
Figure 1, is initiated with the growth and harvesting of the natural raw material (the most viable
source for commercial use at this point appears to be wood, although for research purposes many
other sources are being used, including cotton [6,33,34], banana stems [8], and tunicates) [7,35] and
continues with its isolation, the modiﬁcation and integration into a material system (e.g., compounding
with a polymer), and further processing in order to create a ﬁnal ‘product’, which, eventually, is placed
on the market. The life-cycle continues thereafter with further processing prior to disposal, which may
occur through biodegradation or incineration. Throughout this life-cycle, there is the possibility of
exposure to humans, eventually after nanocellulose is released from the product and through a number
of environments and scenarios. In each of these there are different modes of human exposure, which
include the respiratory tract (inhalation), skin contact, eye contact, ingestion and possible interaction
with the bloodstream (i.e., via direct injection through medical application, or via translocation from
the lung following inhalation [32,36]) resulting in possible secondary organ exposure, i.e., liver, heart,
brain, and/or kidney.
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 Figure 1. Schematic of the life-cycle of cellulose nanocrystals and products made from these
nanoparticles. There are ﬁve main points in the life-cycle of CNCs; i. isolation, ii. compounding,
iii. product formation, vi. post manufacturing processing and use, and v. disposal. All stages of the
life-cycle pose a potential human exposure scenario for which both the exposure level and the hazard
associated, and thus the risk of CNCs to human health, are currently not fully understood. It must be
emphasized that inhalation exposure remains the assumed primary route of entry to the human body
for CNCs.
However, only two major exposure routes have been observed as pertinent to humans during
life-cycles involving anisotropically shaped nanomaterials of this type; inhalation and skin exposure.
This knowledge originates from studies by Maynard and colleagues [37], as well as more recently
by others [38], involving carbon nanotubes (CNTs) and not CNCs. Due to the signiﬁcant differences
between the production, properties and anticipated ﬁelds of use of CNTs [39] and nanocellulose [3], it
must be considered that the exposure routes towards humans could be different, although one can
speculate that inhalation probably would remain the primary form of uptake due to the potential
aerosolisation of the CNCs at this point in their life-cycle. A pertinent association could also be
made with the isolation of bulk cotton ﬁbres [40], although this would arguably only be relevant
to cotton-based CNCs, the exposure risk and routes remain the same (i.e., inhalation and skin
exposure). Naturally, if workers are adequately protected then such exposures can be reduced [41].
However, despite such attention to worker safety, since workers would be exposed to repeated doses
of nanocellulose, over a chronic period of time such an understanding is necessary, as is the speciﬁc
concentrations that they are exposed to. Therefore, to progress knowledge in this area, (i) the human
exposure routes must be conﬁrmed for CNCs at the isolation stage of their life-cycle; and furthermore
(ii) understanding of the occupational exposure levels should be conﬁrmed.
In order to determine the human exposure routes within a nanocellulose production environment,
a number of lessons can be learned from air pollution, as well as those studies focusing on other
nanomaterials [42,43]. It must be noted, however, that the speciﬁc identiﬁcation of aerosolised or
otherwise released nanomaterial fractions, especially ﬁbrous nanomaterials, are highly problematic
and such particles are difﬁcult to measure in any environment due to limitations in the currently
available technology, e.g., with a scanning mobility particle sizer (SMPS) [44]. It is currently unknown
to what extent CNCs can be detected with available methods. Thus, as a starting point, it would be
important to conﬁrm the usefulness of existing analytical tools or develop new methodologies that
permit the accurate measurement of the actual CNC concentration in air, so that these particles can be
detected efﬁciently right from their origin.
The issue of human exposure levels to nanomaterials is, in general, an important issue within
the ﬁeld of nanotoxicology. Recently, intense efforts have been made by the National Institute for
Occupational Safety and Health (NIOSH) in the United States of America. Although it has established
occupational exposure levels for silica dust and titanium dioxide, NIOSH has predominantly focused
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on CNTs, and in a recent central intelligence bulletin suggested an exposure limit for CNTs as 1 μg/m3
for an eight hour working day [45]. Although this recommended exposure limit (REL) could be
considered as an overload situation over a workers’ life-time [46], this metric has been suggested based
on a plethora of in vivo and some in vitro testing strategies using solely CNTs in order to comprehend
speciﬁcity for these nanomaterials. This concept therefore reduces somewhat the applicability towards
an REL for CNCs. However, if the physical characteristics of the nanocellulose sample in question are
remotely comparable to those of the CNTs, then it could be, or might be considered apt. Nonetheless,
the US Occupational Safety and Health Administration had previously set a speciﬁc permissible
exposure limit (PEL) of 200–750 μg/m3 over an eight hour timed weighted average (TWA) for cotton
dust. Irrespective of the issues surrounding both exposure limits, they do provide a signiﬁcant basis
for research to dictate that investigations undertake exposures at ‘realistic’ concentrations/doses so
that extrapolation towards human exposure can be made [47]. Furthermore, such exposure limit
values provide a valuable ‘stop-gap’ until regulatory bodies are able to provide direction towards
the use and exposure of nanomaterials [48]. It is also prudent to note that the REL TWA provided
by NIOSH for silica dust (0.05 mg/m3) [49] could also be used as a ‘highest exposure scenario’ for
CNCs, due to the heightened crystalline fraction (which is the fraction known to drive the heightened
inﬂammatory responses caused following (most) silica exposures) [50]. This concept further highlights
an important note, in general, for the nanotox community regarding the need for the appropriate use of
positive particle controls to use as a comparison for determining the biological impact of nanomaterials,
such as CNCs.
For the subsequent compounding and usage (i.e., product) of CNC-based materials there is also
a risk of exposure, albeit it can be assumed to be much smaller than during the initial isolation of
CNCs. During these latter stages of the life-cycle, the risk of exposure can mostly be attributed towards
the possible abrasion of the product, which could result in the release of individual CNCs, small CNC
aggregates, or nanocellulose-polymer composite (nano)particles, which could be subsequently inhaled
or penetrate through the skin upon contact. Recent research on this matter has again focused upon
CNTs [51–53]. From these initial studies it has been postulated that the release of CNTs, at least in their
bare form and also combined with polymer matrix is relatively low. Speciﬁc exposure levels are not yet
known and therefore additional research must be conducted. Furthermore, in terms of usage, it should
also be noted that there could be direct exposure to the human body via ingestion (e.g., nanocellulose
in contact with food products, such as in food packaging) and also there is the potential injection into
the human bloodstream (e.g., the use of nanocellulose as a tool within nanomedicine). These latter
aspects, however, are currently of minor importance, as the use of nanocellulose as main components
in such food-related and/or medical devices do not appear to be imminent. However, due to their
potential application in these contexts, hazard assessment of these scenarios should be undertaken in
order to obtain clear risk analysis data, as previously shown by Bergin and Witzmann (ingestion of
nanomaterials) [54], as well as for medical application (i.e., injection) [55].
Finally, understanding of the human exposure effects during the disposal of nanocellulose, in
whatever format, is severely limited. A recent study into the incineration of nanomaterials in a waste
plant showed that at a variety of different locations within the building, no or only small amounts
of nanomaterials were found following their incineration [56]. Whilst this could also be true for
nanocellulose, it is safe to assume that, very much like wood, cotton and other raw cellulosic materials
from which CNCs are extracted will end in similar ash once burnt.
Thus, from the currently available information and relevant application of nanocellulose, it can
be summarized that during the entire life-cycle the human exposure routes can be stated in order of
importance as i.e., inhalation > skin > others (e.g., eye contact, ingestion, injection). Such a perspective
is vital towards determining which exposure route hazard analyses should focus upon. This however,
is by no means new information. It can be considered that the entire discipline of nanotoxicology is
predominantly based upon the consideration that most nanomaterials are inhaled and therefore the
lung is the primary human target organ, as is the case within the particle toxicology ﬁeld [57]. However,
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when focusing upon these exposure routes, emphasis should be upon which forms of nanocellulose
to study. Since the potential for inhalation of nanocellulose is most paramount at the isolation stage,
it is fundamental that the biological impact of bare and functionalised CNCs are studied initially.
Such information would then act as a building block in assessing the hazard posed by nanocellulose
released from polymer composites (or a combination thereof), and subsequently the human health
implications during their disposal. For the success of such an outlook however, all nanocelluose
samples would need to undergo essential and thorough characterization.
3. Characterising CNC Exposure
Since the mid-2000s, it has been necessary that a thorough characterisation of the speciﬁc, pristine
nanomaterial being testing for their biological impact is performed [58]. In fact, it is mandatory for
most journals nowadays that such information is contained within all original research manuscripts.
This signiﬁcant change within the ﬁeld of nanotoxicology is evident from the continual association
and signiﬁcant inﬂuence that the physico-chemical characteristics of nanomaterials were noted to
(signiﬁcantly) contribute to the biological effects observed [59]. Although widely accepted, this concept
did however raise multiple discussions as to which physical and/or chemical characteristics must
be studied for each nanomaterial. Due to the diverse nature of nanomaterials, it has so far been too
difﬁcult to deﬁne a precise set of characterisation standards (i.e., which characteristics must researchers
assess?). Mostly the characteristics of shape, size, (chemical) composition, surface material, surface
charge density and surface area [58] have been considered paramount. However, due to analytical
challenges associated with some nanomaterials [60] it has predominantly been accepted that as much
information on the physico-chemical characteristics are provided as possible. Furthermore, assessment
of the physico-chemical characteristics within the biological environment (e.g., for in vitro based
investigations, it is important to determine the impact that the cell culture medium and associated
proteins has upon nanocellulose) studied is desirable [61], yet challenging [62].
Currently there is limited understanding as to the biological impact of nanocellulose in relation to
their physical attributes (throughout their life-cycle), thus developing such knowledge will lend itself
to determining their biocompatibility. Furthermore, such information is important for the future of
nanocellulose hazard assessment, since in a number of previous studies an intimate characterisation is
unfortunately absent, making it difﬁcult to correlate across different studies and to address, if any, the
key parameters that inﬂuence different cell responses following nanocellulose exposure [10].
In order to address this, Table 1 highlights many of the key physico-chemical parameters that
should, ideally, be investigated when studying nanocellulose and CNCs in particular. Furthermore,
the problems associated with each different technique and analytical endpoint is highlighted, with
subsequent suggestions as to how to mitigate such issues. Although all the parameters highlighted in
Table 1 are essential, it is again important to note that the potential hazard of CNCs would likely be
related to (i) their dimensions (i.e., in the nanoscale); and (ii) their ‘ﬁbre-like’ appearance (i.e., long,
straight, and often ‘needle-like’). Whilst the ﬁrst hurdle, their nanoscale dimension, is suitably covered
by the suggested analyses given in Table 1, the latter (i.e., ﬁbre-like appearance) can be related to the
‘ﬁbre paradigm’ [63].
The ﬁbre paradigm itself is associated with the ﬁndings of both glass [64] and asbestos ﬁbers [63].
It was originally shown by Davis and colleagues [65] that long, stiff amosite asbestos ﬁbers, unlike
short amosite asbestos ﬁbres, can lead to serious damage to the lungs of rats when inhaled or following
intraperitoneal injection. Effects noted were chronic inﬂammation leading to eventual granuloma
formation and in some cases mesothelioma (the hallmark cancer of long ﬁbre asbestos exposure).
In regards to glass ﬁbers, often used in construction as an insulating material and ﬁre retardant,
similar heightened negative health effects towards both workers and consumers have been shown
over an increased period [66]. Further research has shown that the speciﬁc health related issues
following exposure to both glass and asbestos ﬁbres include inﬂammation, alveolitis and reduced
pulmonary functions [67]. Importantly, all of this work could only be reported in the manner it was
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due to the speciﬁc physical and chemical characterisation of the ﬁbres investigated. More recently,
CNTs, which are potentially advantageous components for a number of different consumer, industrial,
and technological applications, were shown to induce asbestos-like effects when introduced into the
peritoneal cavity of mice [68]. These results however were attributed to speciﬁc physicochemical
characteristics i.e., increased length and stiffness as well as biopersistence.
For CNCs, concerns associated with the ﬁbre paradigm are debatable as their average lengths
do not ﬁt the required characteristics to ﬁt the paradigm [63]. Indeed, the minimum length for
nanomaterials, or high aspect ratio nanomaterials (HARN), to ﬁt the ﬁbre paradigm is >5 μm [69].
Average dimensions for typical CNCs isolated from cotton (100–200 ˆ 5–15 nm) soft-wood pulp
(100–150 ˆ 5–15 nm), and tunicates (1000–2000 ˆ 10–20 nm) are signiﬁcantly below this threshold [70].
This is, however, not to say that the population of ﬁbres that are longer that 5 μm is zero (especially in
long CNC types such as tunicate CNCs [71]) and that therefore such materials should not elucidate
effects associated with the ﬁbre-paradigm. Indeed, this aspect suggests that CNCs demand special
attention considering their proposed application and possible human exposure. Further need to study
nanocellulose in this notion is that their width (<5 μm) certainly ﬁts the ﬁbre paradigm [63]. The ﬁnal
aspect of this paradigm however, which remains the most difﬁcult to decipher for any (nano)ﬁbre type,
especially nanocellulose, is their biopersistance (or biodurability [72]).
Table 1. Overview of the most commonly used analytical methods for the characterization of the
physico-chemical properties of nanocellulose, in particular CNCs. Details as to the limitations of each
method, with concepts towards mitigation of such limitations also given.
Characterization
Method
Feature of Nanocellulose
Characterised
Limitation Regarding
Nanocellulose Limitation Mitigation References
Electron
Microscopy (TEM)
Shape & dimension
(Best for overall structural
analysis, for most samples)
Drying effects when
spotting onto EM grids
Alter drying conditions,
concentration, BSA-based
techniques [73]
[6,13,74]
Atomic Force
Microscopy (AFM) Shape & dimension
AFM tip has the
potential to
overestimate sizes if
sharpness is lost
Use height (more accurate),
not measured width [75–77]
Dynamic
Light-Scattering (DLS) Overall dimensions
Tough to elucidate
exact dimensions
Modify with an accurate
form factor [78,79]
Optical Photographs
Dispersion/colloidal
stability. Observation of
aggregates (larger than
300 nm)
Limited by Abbe
diffraction limit
Must use electron
microscopy for smaller
(less than 300 nm)
[80,81]
Conductometric
Charge Titration
Charge density (Best for
surface half ester content
determination)
Small (<20 mmol/Kg)
is within noise limit Larger sample size, [6,82]
Elemental Analysis Elemental contentof sample
Common for C, H, N,
S, P analysis only
Must be correlated to
predicted chemical structure [6,83,84]
Infrared
Spectroscopy (IR) Functional groups (bonds)
Only looks at
chemical bonds
Limited to IR active
chemical bonds, sensitivity [78,85]
X-ray Photoelectron
Spectroscopy Elements on the surface
Voxel does not allow
individual
CNC analysis
Does not elucidate groups,
only elements [86]
Brunauer, Emmet and
Teller method (BET) Surface area
Cellulose naturally
aggregates when dried
Aggregation will
lead to lower than
individualized CNCs
[87,88]
Dye Adhesion Surface area Limited by size of dye
Use in conjunction with
other techniques (e.g., rough
estimation by length ˆ
dimension analysis)
[70,89]
Inverse Gas
Chromatography (IGC) Surface properties
Cellulose naturally
aggregates when dried
Aggregation will
lead to lower than
individualized CNCs
[71]
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Previously, biopersistence (associated with exposure to the human lung) of any ﬁbrous material
has been deduced via direct assessment (mostly in acellular and in vivo environments) over a chronic
period. However, in order to reduce animal experimentation in vitro based analyses have also previously
focused on a single-cell system (e.g., macrophages), as well as using different biological-based buffers
at different pH and under flow conditions. Yet, despite these efforts there is currently no clear method
to efficiently and effectively elucidate the potential biopersistence or biodurability of a (nano)fibre.
Currently, knowledge of the biopersistance, or biodurability of nanocellulose is severely lacking,
although several studies are ongoing [31], in order to truly understand its biological impact, efforts
must be made to comprehend this important biological-based characteristic of the material.
4. How to Determine the Potential Biological Impact of Nanocellulose
The biological impact of the bulk form of non-nanoscale cellulose ﬁbres [90] (e.g., microﬁbrilated
nanocellulose) as well as cellulose dust (usually micron sized (>10 μm)) has been widely studied in
the past [91]. Due to the inherent differences between these materials and nanocellulose, it is difﬁcult
to make any clear correlations between them. However, it must be emphasized that non-nanosized
cellulose materials, when compared to other ﬁbrous types, such as asbestos, commonly showed limited
adverse biological effects [92].
Focusing upon CNCs however, a ﬁrst study on the biological impact of CNCs isolated from cotton
and tunicates was reported by Clift and colleagues in 2011 [93]. Further insightful research studies
have followed (Table 2), and have contributed to the current understanding of the biological impact
of CNCs and other nanocellulose types. Despite the increasing number of studies published on this
new nanomaterial in the past few years, in most of the cases a ﬁrst biocompatibility analysis was
performed to assess the possible lethality of the nanocellulose. Yet, a detailed mechanistic toxicological
assessment that is necessary to determine their potential human health effects (over time) remains
lacking. Such analyses are vital, especially considering the landmarks of nanotoxicological research
strategies; i.e., considering the potential for nanocellulose to cause oxidative stress [31,94,95], and
possibly genotoxicity [96]. Such understanding is imperative towards conceiving any understanding
as to the potential (chronic) adverse effects of nanocellulose towards human health. Thus, in order to
achieve such investigations representative models must be utilized, and often in collaboration with
other, complimentary testing strategies.
Commonly, in the past, in vivo studies (e.g., rodent models) have been used to study the toxicology
of nanomaterials, since these allow for whole body exposure scenarios and permit assessing the
biodurability, dissolution and secondary organ toxicity of any test substance. However, in view of the
recent calls for the reﬁnement and reduction of such animal based testing strategies (with a view to
eventually replacing them over time) there is an immediate need to develop alternative testing models,
such as in vitro, in silico and computational models [97]. In a recent review, Hartung and Sabbioni
highlighted the ‘alternative’ models currently available within the ﬁeld of nanotoxicology [98]. Recently,
several advanced and multi-cellular in vitro systems have been used with the objective to determine
the mechanisms behind the possible hazard associated with nanomaterials [99]. Whilst these models
show a different biochemical/biomolecular response to monoculture systems (whether it be a similar
trend, but different concentration-based effects, or a completely different biological effect) [100], there
is still much debate and unknown as to how they correlate to the in vivo scenario, albeit efforts
are underway to address this knowledge gap [101]. Such systems have recently been shown to be
advantageous in determining the hazard posed by nanocellulose [47], as well as its interaction with
cellular systems [102].
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Table 2. An overview over the published studies focussing on the hazard assessment of nanocellulose.
Details regarding the speciﬁc form of nanocellulose used, the biological system employed and the
speciﬁc biochemical endpoint analysed are given.
Nanocellulose Form Studied Biological Model Used Endpoint Assessed Reference
Bacterial cellulose nanoﬁbres
(BC-NF) 3T3 ﬁbroblasts, CHO cells
mutagenicity, proliferation,
genotoxicity [103]
Bacterial cellulose nanoﬁbres HUVEC, C57/Bl6 mice
viability, cytotoxicity,
apoptosis/necrosis,
cell cycle
[104]
Cellulose nanocrystals (CNCs)
Oncorhynchus mykiss hepatocytes,
Daphnia magna, Ceriodaphia dubia,
Pimephales promelas, Vibrio ﬁscheri,
Pseudokirchneriella subcapitata,
Hydra attenuata, Danio rerio
genotoxicity, reproduction,
survival, growth [105]
CNCs isolated from ﬂay HEK 293, Sf9 cells uptake, cytotoxicity [106]
CNCs isolated from cotton
and tunicates
3D model of the pulmonary
epithelial airway barrier
cytotoxicity,
(pro)inﬂammatory response [93]
Cellulose nanoﬁbers isolated
from caraua/cotton
Allium cepa, primary lymphocytes,
3T3 ﬁbroblasts Genotoxicity [107]
Plant derived CNCs
HBMEC, bEnd.3, RAW 264.7,
MCF-10A, MDA-MB-231,
MDA-MB-468, KB, PC-3, C6 cells
uptake, cytotoxicity [108]
Nanoﬁbrillated cellulose (NFC) BEAS 2B cells Genotoxicity [109]
CNCs isolated from cotton,
ﬂax, hemp V79 ﬁbroblast, Sf9 cells Cytotoxicity [110]
Cotton cellulose
nanoﬁbres (CNF) Bovine ﬁbroblasts
cytotoxicity, stress
response, apoptosis [111]
CNCs isolated from cotton BEAS 2B cells, monocyte-derivedmacrophages
cytotoxicity, genotoxicity,
inﬂammatory response [112]
CNCs isolated from MCC NIH3T3 ﬁbroblasts, HCT116 cells cell viability [113]
CNFs isolated from cotton Chlorella vulgaris cell viability, growth [114]
CNCs isolated from wood C57BL/6 mice pulmonary outcome [115]
Whilst the speciﬁc mechanisms associated with and driving any of the observed biochemical
and biomolecular reactions measured are a necessity, it is vital that a speciﬁc understanding of how
nanocellulose interacts with different biological systems can be developed, and how this relates to the
biochemical response measured. The use of state-of-the-art microscopy approaches will be necessary
due to the innate difﬁculties in identifying nanocellulose within cellular structures. A recent study by
Endes et al. showed the possibility to achieve imaging of CNCs within cells by ﬂuorescently labelling
the nanocellulose used, with the assumption that small amounts of dye, in this case ﬂuorescein,
does not have any signiﬁcant effect on the associated tests, such as uptake or cytotoxicity [102].
Analytical techniques should be sought out, which can directly identify cellulose, without the need
of modiﬁcation to easily identify nanocellulose inside cells so that a toxicodynamic approach can be
undertaken. Finally, once all this information is gained, then correlatory analysis against the speciﬁc
physical and chemical characteristics of the nanocellulose sample so that efforts can be made to negate
the production of such materials exhibiting these characteristics (i.e., safe-by-design nanomaterials).
It should be noted, that this article focuses on cellulouse nanocrystals. One of the greatest
challenges in addressing the effect of nanocellulose, is that it comes in many different forms, not only
with respect to source, aspect ratio and surface chemistry, and processing methods. These different
forms usually focus on different systems, in different ways. Although the above table suggests the
majority of research is focused on CNCs, there are others, which is beyond the scope of this paper.
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Nonetheless, the discussion contained within the present perspective would certainly ﬁt towards any
and all nanocellulose types.
5. Summary and Outlook
Nanocellulose is an interesting tool for material scientists as the platform to engineer desired
functions into polymeric and biological systems. Many research groups have found a plethora of
ways to use cellulose in both its bare, and functionalized form. These applications have shown that
both in vitro and in vivo applications are viable, and do not create any measurable negative effects.
Along with its production/isolation, the commercialization of products containing nanocellulose has
begun and is constantly increasing. Several avenues of use seem to be emerging for nanocellulose,
from high end smart and biocompatible materials, to large-scale use in commodity products. All these
exciting properties of cellulose nanocrystals and cellulose based nanomaterials seem to be to the
beginning of a new concept of enhanced commodity materials and specialized biomedicine in which
materials science and biology are closely related; giving the opportunity to engineer the desired
material using nanomaterials.
With all of these obvious advantages, there remains a lack of knowledge concerning the potential
hazard nanocellulose may pose to human health, and furthermore at how, if, and at what dose
humans would be exposed, given the wide range of potential life-cycle scenarios. Although there
has been much research-based emphasis on deducing this unknown, and so far no adverse acute
effects have been reported when using realistic concentrations, a variety of compounding factors
disallow any meaningful wide-ranging understanding to be gained from the research currently
available. Varying characteristics of the investigated sample deriving from differing production
protocols, sources, dimensions, purity, concentration, application mode and exposure time can strongly
inﬂuence the biological response observed in vitro or in vivo and may not reﬂect a realistic assessment
of the potential hazard of cellulosic ﬁbres in general and in particular for cellulose nanocrystals.
Therefore, in order to realize these aspects, and overcome these issues, it is suggested to consider
the following points in order to fully, and holistically deduce the potential human health risk
of nanocellulose;
‚ Assess and quantify what and if the released dose at each stage of the material’s life-cycle is
a potential mode for environmental as well as human exposure (e.g., inhalation and skin contact).
‚ At each stage of the life-cycle of nanocellulose undertaken, thorough characterisation of the
released nanomaterial (if any) and decipher between single nanocellulose nanoﬁbers, polymer
composite released nanocellulose nanoﬁbers and micron-sized particles. Several parameters need
to be analyzed, the most relevant factors being: the dimensions (width, length, aspect ratio),
colloidal stability on the studied medium, surface chemistry, speciﬁc surface area and degree of
crystallinity (directly related to the stiffness of the material).
‚ In order to achieve the characterisation of the materials at every life-cycle stage, reliable
and representative methods must be used (as suggested in Table 1). The need to develop
alternative or adapted methods for every nanomaterial, especially nanocellulose remains and
is the responsibility of the ﬁeld to progress. New protocols need to be established for the facile
characterization and determination of nanoparticle size and determination of surface chemistry
on the nanoscale, which allow for a simple and realistic comparison between studies.
‚ Understanding of the acute and chronic effects of nanocellulose exposure, particularly during
occupational exposure (i.e., isolation stage) in order to comprehend the ability for nanocellulose
to either contribute to, or exacerbate pre-existing disease states.
‚ Determine the biomolecular and biochemical mechanisms that drive, if any, the (adverse)
biological effects following nanocellulose exposure.
‚ The application of realistic doses in contrast to overload situations on target organ (in vitro) or
related systems has to be the aim in any hazard assessment study.
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‚ Relate the exposure dose effect and associated biochemical effects to the speciﬁc characteristics
of the nanocellulose investigated in order to determine the speciﬁc physical and/or chemical
characteristics that might be driving the possible hazardous response measured.
It is the hope that such suggestions towards the assessment of biological interactions and impact
of nanocellulose to human health provides coherent and effective knowledge and understanding that
can be put towards the development of regulatory guidelines for the production, use and disposal of
nanocellulose. Further to this, elucidation of the biological impact of nanocellulose will only serve
towards realizing the plethora of advantages posed by this naturally occurring material.
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